Janux Therapeutics, Inc. (JANX)

Janux Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Cash & Equivalents	27.77	51.83	52.33	48.39	52.45	73.74	430.61	26.75	14.66	212.8	19.21	17.15	33.7	30.36	51.43	64.75	58.4	55.13	35.58	39.39
Short-Term Investments	943.15	904.56	914.23	940.6	943.57	940.4	594.57	631.28	631.63	438.96	324.82	332.56	269.59	286.52	275.59	274.01	295.89	306.07	339.38	348.12
Cash & Short-Term Investments	970.91	956.39	966.57	988.99	996.01	1,014	1,025	658.03	646.29	651.76	344.03	349.71	303.29	316.88	327.02	338.76	354.3	361.2	374.97	387.51
Cash Growth (YoY)	-2.52%	-5.70%	-5.72%	50.30%	54.11%	55.60%	197.99%	88.16%	113.09%	105.69%	5.20%	3.23%	-14.40%	-12.27%	-12.79%	-12.58%	-10.12%	410.39%	4699.24%	-
Accounts Receivable	0.15	35	-	-	-	-	-	-	7.5	0.52	-	-	-	0.75	-	0.5	-	-	-	-
Other Receivables	6.18	7.46	6.43	6.32	5.69	5.59	5.38	4.45	4.56	3.89	2.16	1.7	1.5	0.7	0.7	0.3	0.3	0.1	0.2	0.03
Receivables	6.33	42.46	6.43	6.32	5.69	5.59	5.38	4.45	12.06	4.41	2.16	1.7	1.5	1.45	0.7	0.8	0.3	0.1	0.2	0.03
Prepaid Expenses	6.1	3.2	2.89	2.78	3.85	3.61	3.11	3.84	3.59	2.5	3.05	3.78	4.51	3.07	4.72	4.77	3.47	3.35	1.85	2.05
Total Current Assets	983.34	1,002	975.89	998.09	1,006	1,023	1,034	666.32	661.94	658.67	349.24	355.2	309.3	321.4	332.44	344.33	358.07	364.65	377.02	389.59
Property, Plant & Equipment	20.59	21.42	22.25	23.24	23.15	23.83	24.15	25.06	26.02	26.98	27.84	28.53	28.95	29.13	29.37	29.18	26.28	2.79	1.6	1.36
Other Long-Term Assets	3.73	4.76	3.42	3.44	3.51	3.61	3.7	3.64	3.46	3.34	3.33	3.13	3.25	2.43	2.21	2.25	1.02	1.15	1.21	0.14
Total Assets	1,008	1,028	1,002	1,025	1,032	1,051	1,062	695.02	691.41	688.98	380.41	386.85	341.5	352.96	364.01	375.76	385.37	368.6	379.82	391.08

Liabilities

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Accounts Payable	3.02	3.38	4.97	3.4	3.48	2.35	4.03	2.46	1.25	2.25	2.42	2.51	1.91	2.05	2.16	2.87	3	1.94	2.46	3.61
Accrued Expenses	19.51	15.48	17.63	22.16	16.03	13.34	11.68	13.02	8.57	5.81	7.39	6.83	9.22	7.74	8.18	7.24	4.04	5.07	3.78	2.03
Current Portion of Leases	2.55	2.47	2.39	2.28	1.87	1.81	1.75	1.69	1.63	1.57	1.52	1.46	1.41	1.36	0.76	-	0.09	0.15	0.19	0.21
Current Unearned Revenue	35.07	37.59	-	-	-	-	-	-	0.09	0.97	1.71	3.65	5.34	4.94	5.41	5.91	5.37	4.65	5.16	5.26
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	0.03	0.03	0.04	-	0.32	0.49	0.7	1.2	1.35
Total Current Liabilities	60.15	58.92	25	27.83	21.38	17.5	17.46	17.17	11.55	10.61	13.03	14.47	17.9	16.11	16.51	16.34	12.99	12.52	12.8	12.47
Long-Term Leases	18.44	19.1	19.75	20.38	20.32	20.8	21.28	21.74	22.19	22.61	23.03	23.43	23.82	24.18	24.54	24.09	23.27	-	-	0.02
Long-Term Unearned Revenue	1.08	8.68	-	-	-	-	-	-	-	-	-	-	0.31	1.39	2.22	3.82	5.29	-	0.7	1.84
Total Liabilities	79.67	86.69	44.74	48.21	41.7	38.3	38.74	38.92	33.74	33.22	36.06	37.9	42.03	41.69	43.27	44.24	41.55	12.52	13.5	14.33

Shareholders' Equity

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.05	0.05	0.05	0.05	0.05	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04
Additional Paid-In Capital	1,328	1,317	1,304	1,291	1,282	1,270	1,258	865.76	848.72	839.76	512.4	507.08	445.92	439.89	432.7	428.15	423.39	418.43	413.97	410.68
Retained Earnings	-397.72	-375.74	-351.38	-319.44	-295.12	-261.27	-237.76	-217.54	-189.48	-183.52	-168.76	-157.01	-145.44	-127.93	-110.47	-94.41	-77.71	-60.82	-47.41	-34
Comprehensive Income & Other	-2.31	0.58	4.32	4.56	3.75	3.76	2.16	7.83	-1.62	-0.52	0.67	-1.18	-1.06	-0.74	-1.54	-2.28	-1.91	-1.57	-0.27	0.02
Total Common Equity	927.98	941.54	956.82	976.56	990.52	1,012	1,023	656.1	657.68	655.76	344.35	348.95	299.47	311.26	320.74	331.51	343.81	356.08	366.33	376.75
Shareholders' Equity	927.98	941.54	956.82	976.56	990.52	1,012	1,023	656.1	657.68	655.76	344.35	348.95	299.47	311.26	320.74	331.51	343.81	356.08	366.33	376.75
Total Liabilities & Equity	1,008	1,028	1,002	1,025	1,032	1,051	1,062	695.02	691.41	688.98	380.41	386.85	341.5	352.96	364.01	375.76	385.37	368.6	379.82	391.08

Additional Metrics

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Total Debt	20.99	21.57	22.14	22.66	22.19	22.61	23.03	23.43	23.82	24.19	24.54	24.89	25.23	25.54	25.31	24.09	23.36	0.15	0.19	0.24
Net Cash (Debt)	949.92	934.82	944.43	966.33	973.82	991.53	1,002	634.6	622.47	627.58	319.49	324.82	278.06	291.34	301.71	314.67	330.94	361.05	374.77	387.27
Net Cash Growth (YoY)	-2.45%	-5.72%	-5.76%	52.27%	56.44%	57.99%	213.68%	95.37%	123.86%	115.42%	5.89%	3.23%	-15.98%	-19.31%	-19.50%	-18.75%	-16.05%	410.18%	4696.76%	-
Net Cash Per Share	15.09	14.92	15.20	15.58	15.73	16.05	17.63	11.62	11.43	12.79	6.84	7.11	6.65	6.98	7.26	7.58	7.98	8.74	9.09	9.41
Filing Date Shares Outstanding	61.14	60.98	60.83	60.15	60.09	59.18	59.11	52.48	52.16	51.84	51.65	46.15	46.12	41.8	41.76	41.55	41.5	41.39	41.24	41.61
Total Common Shares Outstanding	61.08	60.87	60.38	60.12	59.3	59.17	59.06	52.33	52.16	51.84	46.24	46.13	41.87	41.8	41.62	41.55	41.5	41.39	41.24	41.61
Working Capital	923.19	943.13	950.89	970.26	984.17	1,006	1,016	649.15	650.39	648.06	336.21	340.72	291.4	305.29	315.93	328	345.07	352.14	364.22	377.12
Book Value Per Share	15.19	15.47	15.85	16.24	16.70	17.11	17.32	12.54	12.61	12.65	7.45	7.56	7.15	7.45	7.71	7.98	8.28	8.60	8.88	9.05
Tangible Book Value	927.98	941.54	956.82	976.56	990.52	1,012	1,023	656.1	657.68	655.76	344.35	348.95	299.47	311.26	320.74	331.51	343.81	356.08	366.33	376.75
Tangible Book Value Per Share	15.19	15.47	15.85	16.24	16.70	17.11	17.32	12.54	12.61	12.65	7.45	7.56	7.15	7.45	7.71	7.98	8.28	8.60	8.88	9.05
Machinery	11.08	10.72	10.82	10.73	10.68	10.18	9.81	9.82	9.83	9.96	9.87	9.36	8.79	8.35	7.91	6.92	2.18	2.02	1.4	1.04
Construction In Progress	-	-	-	-	-	-	-	-	-	-	-	-	-	0.27	-	0.16	1.66	0.85	0.14	0.14

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 10, 2026

Data Sources Report a data error